NOLA-B

Nolato is a global development and production partner that develops and manufactures products primarily in polymeric materials, including plastics, silicone, and thermoplastic elastomers. The company operates through two business segments: Medical Solutions and Engineered Solutions. Medical Solutions develops advanced components, subsystems, and complete products for medical technology, pharmaceuticals, and diagnostics, with a focus on drug delivery systems for diabetes and obesity treatment. Engineered Solutions produces technically advanced components, subsystems, and finished products for industries such as automotive, electronics, and telecommunications, offering solutions for electromagnetic shielding and thermal management. The company serves global customers across Europe, Asia, and North America, with manufacturing and sales operations in multiple countries including Sweden, Hungary, China, Malaysia, Poland, and the United States. Nolato was founded in 1938 as Nordiska Latexfabriken i Torekov and adopted the name Nolato in 1982. The company holds the Trishield trademark for dispensed gaskets and operates Technical Design Centers to support customer development.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Specialty Chemicals Homepage nolato.com
Sector Basic Materials IR page nolato.com/investor-relations
Tags
polymer processing, medical devices, pharmaceutical packaging, drug delivery, electromagnetic shielding, thermal management, consumer electronics, automotive components, silicone molding, in-vitro diagnostics, Medical Solutions, Engineered Solutions, Trishield, Nolato MediTech, Nolato Jaycare, Nolato Jabar, Nolato PPT, Be-Må Molds, Nolato Unitron, Nolato Qualtech, Nolato Stargard, Nolato Treff, Nolato Contour, Nolato Protec, Nolato Gejde, Nolato Polymer, Nolato Silikonteknik, Nolato MediTor, Nolato Hertila, Nolato Lövepac, Nolato Cerbo, Nolato Medical Rubber, Nolato Alpha, Nolato Mobile, Nolato Autec, Nolato Mobitec, Nolato Jász, Nolato Tallinn, Nolato Beijing, Nolato Texas, Nolato Shieldmate, Nolato Elastoteknik, Nolato Sunnex Equipment, Nolato Medevo, Nolato Telecom, Nolato Industrial, Nolato Medical, Nolato Hungary, Nolato Kuala Lumpur, Nolato Shenzhen, Nolato Chennai, Nolato Romania
Press page nolato.com/investor-relations/investor-information/press-releases

Metrics

Valuation  
Market cap kr 14.627B
Market cap (USD) $ 1.447B
P/E 22.89
PEG 6.21
P/BV 2.64
P/S 1.55
P/OCF 13.77
P/FCF —
Dividend yield 2.8%
Turnover / mcap —
Returns  
ROE 13.8%
ROI 12.1%
ROIC 12.6%
Profit margin 8.2%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 3.7%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 16.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 26
Quality score 33.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Revenue 9.462B 9.664B 9.546B 10.774B 11.61B 9.359B 7.919B 8.102B 6.72B 4.447B 4.726B 4.234B 4.522B 3.874B 2.977B 3.375B 2.602B
Net profit — 658M 435M 697M 1.16B 806M 703M 722M 572M 336M 420M 364M 314M 202M 132M 187M 123M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Share price 61.8 54.2 52.9 54.65 107.9 — 55 — — — — — — — — — —
Price performance 12m 0.14 0.02 -0.03 -0.49 0.3 — — — — — — — — — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (SEK) — 1.25B 1.57B 1.52B 1.53B 1.56B 1.6B
↳ YoY growth +25.5% -3.3% +0.2% +2.2% +2.7%
↳ 5y CAGR +5.0%
Cash and deposits (SEK) 1.36B 1.49B 1.45B 1.01B 688M 672M 482M
Right-of-use assets (SEK) — 353M 287M 305M 282M 181M 209M
Cash flow detail
Operating cash flow (SEK) — 1.16B 1.23B 406M 781M 1.38B 1.06B
Purchases of property, plant and equipment (SEK) — -368M -776M -451M -426M -635M -784M
Purchases of intangible assets (SEK) — -5M -6M -4M -4M -5M -5M
Change in receivables (cash effect) (SEK) — -12M -218M 181M -20M 39M -183M
Change in inventories (cash effect) (SEK) — -41M -423M 176M 81M 64M -6M
Change in payables (cash effect) (SEK) — -6M 441M -788M -137M 23M 7M
Dividends paid (cash effect) (SEK) — 0.00 -428M -512M -512M -404M -404M
Interest paid (cash effect) (SEK) — -36M -44M -56M -69M -68M -52M
Income taxes paid (cash effect) (SEK) — -123M -203M -239M -151M -140M -220M
Operating cash flow before change in receivables (SEK) — 1.18B 1.45B 225M 801M 1.34B 1.25B
Free cash flow (OCF - PPE - intangibles) (SEK) — 791M 446M -49M 351M 737M 273M
Income detail
Total comprehensive income (SEK) — 636M 1.4B 1.13B 283M 964M 191M
Comprehensive income to owners (SEK) — 636M 1.4B 1.13B 283M 964M 191M
Reported — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Third quarter of 2026 in brief: Sales rose to SEK 2,500 million (2,342) – adjusted for currency and acquisitions, this was a 3% increase; Operating profit (EBITA) was SEK 254 million (281); EBITA marg...

Subscribe to press releases

  1. Investor relations

  2. Investor information

  3. Press releases

  4. 2026

  5. Strategic acquisitions and strong organic growth for Medical Solutions

Strategic acquisitions and strong organic growth for Medical Solutions

Oct 29, 2026, 07:45

Regulatory Interim report

Third quarter of 2026 in brief

  • Sales rose to SEK 2,500 million (2,342) – adjusted for currency and acquisitions, this was a 3% increase
  • Operating profit (EBITA) was SEK 254 million (281)
  • EBITA margin of 10.2% (12.0)
  • Profit after tax was SEK 172 million (215)
  • Earnings per share, basic and diluted, totaled SEK 0.64 (0.80)
  • Cash flow from operating activities increased to SEK 332 million (301)

Business area performance

Medical Solutions sales amounted to SEK 1,469 million (1,311) which, adjusted for currency and acquisitions, is an increase of a full 9%. Operating profit (EBITA) rose to SEK 166 million (159) and the EBITA margin was 11.3% (12.1). The business area saw growth in most market areas, particularly Drug delivery, driven by increased volumes of several newer products, and also In vitro diagnostics (IVD), where newer products account for the majority of the increase. Investments in expansion to support future growth are proceeding according to plan at several of our existing facilities. The acquisitions of the Dutch company Unitron and part of the Irish company Qualtech are included in the quarter on a one-month basis and have been successfully completed; the majority of their sales are included in the Drug delivery market area.

Engineered Solutions sales amounted to SEK 1,040 million (1,035); adjusted for currency and acquisitions, this was a decrease of 3%. Operating profit (EBITA) decreased to SEK 112 million (120) and the EBITA margin amounted to 10.8% (11.6). The Consumer electronics market segment exhibited stable volumes while Automotive declined sharply due to lower demand and the impact of model changes among customers. Hygiene continued to see inventory adjustments and lower sales, although volumes have stabilized sequentially. The market area Other grew; it now includes the majority of the business area’s share of the acquisition of Irish company Qualtech, which contributed on a one-month basis in the quarter.

Materials exhibited a sharp increase in volume and is contributing robust profitability. All customer segments exhibited growth and, in particular, shipment volumes for data centers/satellites, aerospace/defense, and the automotive sector increased significantly.

A one-time item of SEK 8 million for acquisition costs was charged to consolidated profit. In the previous year, profit was positively affected by a one-time item of SEK 7 million net related to an insurance claim.

First nine months of 2026 in brief

  • Group sales rose to SEK 7,311 million (7,190) – adjusted for currency and acquisitions, this was a 3% increase
  • Group operating profit (EBITA) was SEK 761 million (829)
  • The EBITA margin was 10.4% (11.5)
  • Profit after tax was SEK 522 million (626)
  • Earnings per share, basic and diluted, totaled SEK 1.94 (2.32)
  • Cash flow from operating activities increased to SEK 844 million (752)
  • Sustained strong financial position

Comments from the CEO

Anders Björklund, President and CEO of Nolato AB, commented:

Group sales increased by 7% in the third quarter. Adjusted for acquisitions and currency effects, organic growth was 3% in a persistently challenging business environment. However, we have a diversified customer portfolio and production on three continents, which generally gives us good resilience. Nevertheless, we are temporarily affected by higher prices for input goods, which was partly a reason for the EBITA margin declining to 10.2%.

Nolato continuously optimizes its business portfolio to strengthen its position in areas where we can combine technical expertise, close customer relationships and industrial scale in a global market. Through the recently completed acquisitions of Unitron and M&M Qualtech, Nolato is strengthening its capacity in electronics-intensive medical technology, systems integration and advanced manufacturing. The acquisitions broaden Nolato’s offering by adding development expertise and manufacturing of complete systems – including electronics – which strengthen Nolato’s presence in attractive, regulated segments and provide means for taking on greater responsibility in customers’ value chains. The acquisitions, which were consolidated as of September, contribute approximately SEK 600 million on an annual basis, with an EBITA margin in line with that of the Group.

Nolato’s financial position remains very strong, with net liabilities in relation to operating profit (EBITDA) of 1.0x at the end of the third quarter, providing us with continued financial flexibility.

Nolato AB will publish its interim report for the third quarter of 2026 on Thursday October 29 at 7.45 a.m. CEST. In connection with the report, Nolato will the same day hold a webcast conference call...

Subscribe to press releases

  1. Investor relations

  2. Investor information

  3. Press releases

  4. 2026

  5. Webcast conference call on October 29 about Nolato’s interim report for Q3 2026

Webcast conference call on October 29 about Nolato’s interim report for Q3 2026

Oct 22, 2026, 10:00

Non-regulatory Press release

Nolato AB will publish its interim report for the third quarter of 2026 on Thursday October 29 at 7.45 a.m. CEST. In connection with the report, Nolato will the same day hold a webcast conference call in English at 8.45 a.m. CEST.

Nolato will be represented by President and CEO Anders Björklund and CFO Per-Ola Holmström, who will present the report and answer questions.

DATE, TIME AND LINKS

Publication of the report:
Thursday October 29 at 7.45 a.m. CET

Webcast conference call (in English):
Thursday October 29 at 8.45 a.m. CET

Link for those who want to participate via the web:
https://www.finwire.tv/webcast/nolato/q3-2026/

Telephone number for those who wish to participate by telephone:
+46 850 163 827
Code: 876 0042 7751#
To ask a question, press *9 on the phone.
To withdraw the question press *9 again.
To mute/unmute, press *6. When connected, the phone is on mute.
The conference leader controls the order of questions.

Presentation, recording and transcript:
The presentation used during the conference call can be downloaded in connection with the publication of the report at www.nolato.com/reports.

After the live broadcast a recording and a transcript of the webcast will be available at www.nolato.com/reports.

About Us


Nolato is a Swedish group with operations in Europe, Asia, and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, consumer electronics, telecom, automotive, hygiene and other selected industrial sectors. Nolato’s shares are listed on Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector.  _www.nolato.com/IR _

Enclosed documents

Webcast conference call on October 29 about Nolato’s interim report for Q3 2026

Press releases

Logotype

Experience & Innovation

© Nolato AB (publ), Nolatovägen 32, 269 78 Torekov, Sweden

Cecilia Hellner has been appointed Head of Nolato’s Engineered Solutions business area and a member of the Group Management. Cecilia Hellner, 50, has been Managing Director of Nolato Cerbo, one of Nol...

Subscribe to press releases

  1. Investor relations

  2. Investor information

  3. Press releases

  4. 2026

  5. Nolato appoints Cecilia Hellner Head of Engineered Solutions

Nolato appoints Cecilia Hellner Head of Engineered Solutions

Oct 12, 2026, 10:45

Regulatory Press release

Cecilia Hellner has been appointed Head of Nolato’s Engineered Solutions business area and a member of the Group Management. Cecilia Hellner, 50, has been Managing Director of Nolato Cerbo, one of Nolato’s subsidiaries, since 2021. She holds a Master of Science in Engineering from Chalmers University of Technology and spent most of her earlier career at AB Volvo, where she held several senior positions.

Going forward, Nolato’s Group Management will comprise Anders Björklund (President and CEO), Per-Ola Holmström (Deputy CEO and CFO), Johan Iveberg (President of Medical Solutions), Cecilia Hellner (President of Engineered Solutions), Anders Ericsson (MD of Nolato Silikonteknik and Head of Materials), Camilla Magnusson (Group Procurement Director), Glenn Svedberg (Sustainability Director and Technology Director) and Rickard Dahlgren (Head of Strategy and M&A).

Nolato initiated the recruitment process for a new Head of Engineered Solutions during the second quarter of 2026, following the appointment of the former business area head, Anders Björklund, as President and CEO of Nolato.

Prompts

Nolato (ticker NOLA-B), listed in Sweden.

ETFs Holding Nolato

ETF Weight in ETF Shares Market value As of
AVDS 0.05% 37,202 $ 196.304K Nov 16, 2026
AVDV 0.04% 1,538,375 $ 8.118M Nov 16, 2026
DFIS 0.02% 228,064 $ 1.201M Nov 12, 2026
DXIV 0.01% 4,793 $ 25.233K Nov 12, 2026
AVDE 0.01% 487,649 $ 2.573M Nov 16, 2026
DFAX 0.01% 153,379 $ 807.468K Nov 12, 2026
DFIC 0.01% 151,720 $ 798.734K Nov 12, 2026
DFAI 0.00% 152,877 $ 804.825K Nov 12, 2026
DFSI 0.00% 7,560 $ 39.8K Nov 12, 2026